The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients.

Nabeel KhanDhruvan PatelChinmay TrivediTyler PernesHimanshu KavaniDawei XieYu-Xiao Yang

Published in: Alimentary pharmacology & therapeutics (2021)

Anti-TNF medications and prednisone use may be associated with increased risk of developing pneumonia and pneumonia-related hospitalisation. Physicians should evaluate the risk-benefit ratio of IBD medications, especially in the elderly population.

Keyphrases

end stage renal disease
ejection fraction
primary care
chronic kidney disease
community acquired pneumonia
respiratory failure
newly diagnosed
ulcerative colitis
peritoneal dialysis
acute respiratory distress syndrome